Toshihiro Tajima Selected Research

Salts

1/2021	The progression of salt-wasting and the body weight change during the first 2 weeks of life in classical 21-hydroxylase deficiency patients.
11/2020	Clinical Features of 57 Patients with Lipoid Congenital Adrenal Hyperplasia: Criteria for Nonclassic Form Revisited.
7/2015	Two Japanese patients with the renal form of pseudohypoaldosteronism type 1 caused by mutations of NR3C2.
4/2014	Results from 28 years of newborn screening for congenital adrenal hyperplasia in sapporo.
12/2013	Classic Bartter syndrome complicated with profound growth hormone deficiency: a case report.
1/2013	Two novel mutations of the CYP11B2 gene in a Japanese patient with aldosterone deficiency type 1.
1/2013	Clinical and molecular analysis of six Japanese patients with a renal form of pseudohypoaldosteronism type 1.
6/2010	Increased Na reabsorption via the Na-Cl cotransporter in autosomal recessive pseudohypoaldosteronism.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Toshihiro Tajima Research Topics

Disease

12	Hypothyroidism 01/2022 - 10/2005
7	Pseudohypoaldosteronism 08/2020 - 06/2010
7	Hypokalemia 01/2014 - 02/2002
6	Congenital Hypothyroidism (Cretinism) 07/2016 - 12/2007
5	Congenital adrenal hyperplasia due to 21 hydroxylase deficiency 02/2024 - 01/2015
5	Gitelman Syndrome 01/2014 - 02/2002
5	Alkalosis 02/2012 - 02/2002
4	Hypoparathyroidism 02/2015 - 07/2002
4	Bartter Syndrome (Syndrome, Bartter) 12/2013 - 05/2005
4	Nephrocalcinosis 08/2009 - 07/2002
3	Inborn Genetic Diseases (Disease, Hereditary) 01/2020 - 03/2008
3	Combined Pituitary Hormone Deficiency 01/2019 - 02/2010
3	Nephrogenic Diabetes Insipidus 01/2018 - 08/2003
3	Congenital Adrenal Hyperplasia (Hyperplasia, Congenital Adrenal) 01/2018 - 01/2008
3	Hypercalciuria 08/2009 - 07/2002
3	Antley-Bixler Syndrome Phenotype 05/2009 - 11/2004
2	Fever (Fevers) 01/2023 - 10/2022
2	Hypogonadism (Hypergonadotropic Hypogonadism) 01/2022 - 03/2008
2	Precocious Puberty 01/2022 - 12/2017
2	Adrenal Insufficiency (Adrenal Gland Hypofunction) 08/2020 - 05/2005
2	Cataract (Cataracts) 12/2017 - 08/2009
2	Muscle Hypotonia (Hypotonia) 12/2017 - 10/2013
2	Hypoglycemia (Reactive Hypoglycemia) 01/2017 - 12/2013
2	Diabetes Mellitus 01/2017 - 02/2006
2	Body Weight (Weight, Body) 09/2016 - 04/2012
2	Pseudohypoparathyroidism 01/2016 - 03/2008
2	Type 2 Diabetes Mellitus (MODY) 01/2015 - 02/2012
2	Rare Diseases (Rare Disease) 09/2014 - 01/2013
2	Hyperaldosteronism (Conn Syndrome) 01/2014 - 10/2006
2	type 1 familial Hypocalciuric hypercalcemia 10/2013 - 01/2010
2	Insulin Resistance 02/2012 - 02/2002
2	Hypocalcemia 08/2009 - 07/2002
2	Virilism (Virilization) 05/2009 - 01/2008
2	Disorders of Sex Development (Intersexuality) 05/2009 - 01/2008
2	Astrocytoma (Pilocytic Astrocytoma) 05/2009 - 10/2008
2	Hyperplasia 01/2008 - 06/2003
2	Renal Insufficiency (Renal Failure) 12/2007 - 12/2003
1	Papilledema 01/2023
1	Pain (Aches) 01/2023
1	Camurati-Engelmann Syndrome (Progressive Diaphyseal Dysplasia) 01/2023
1	Chest Pain (Chest Pains) 10/2022
1	Myocarditis (Carditis) 10/2022
1	Phenylketonurias (Phenylketonuria) 01/2022
1	Homocystinuria 01/2022
1	Galactosemias (Galactosemia) 01/2022
1	Autoimmune Thyroiditis (Lymphomatous Thyroiditis) 01/2021
1	Body Weight Changes 01/2021
1	Addison Disease (Addison's Disease) 11/2020

Drug/Important Bio-Agent (IBA)

8	SaltsIBA 01/2021 - 06/2010
7	Thyroxine (Levothyroxine)FDA LinkGeneric 01/2022 - 01/2008
7	PotassiumIBA 01/2020 - 02/2002
6	Hormones (Hormone)IBA 01/2019 - 05/2005
6	AldosteroneIBA 01/2017 - 02/2012
6	MagnesiumIBA 08/2009 - 02/2002
5	Hydrocortisone (Cortisol)FDA LinkGeneric 11/2022 - 01/2013
5	Insulin (Novolin)FDA Link 12/2017 - 02/2002
4	SteroidsIBA 11/2022 - 06/2003
4	ReninIBA 01/2020 - 02/2012
3	Immunoglobulins (Immunoglobulin)IBA 01/2022 - 12/2016
3	SodiumIBA 08/2020 - 08/2009
3	ProlactinIBA 03/2018 - 07/2008
3	Thyroid HormonesIBA 03/2018 - 10/2013
3	CalciumIBA 07/2017 - 07/2002
3	Thyrotropin (Thyroid-Stimulating Hormone)FDA Link 09/2014 - 12/2007
3	Chloride Channels (Chloride Channel)IBA 12/2013 - 05/2005
3	Growth Hormone (Somatotropin)IBA 12/2013 - 07/2008
3	Calcium-Sensing ReceptorsIBA 10/2013 - 07/2002
3	trans-sodium crocetinate (crocetin)IBA 07/2008 - 02/2002
2	Thyrotropin Receptors (Thyrotropin Receptor)IBA 01/2021 - 06/2014
2	Dietary PotassiumIBA 08/2020 - 01/2020
2	Epithelial Sodium ChannelsIBA 01/2020 - 06/2010
2	Proteins (Proteins, Gene)FDA Link 01/2018 - 02/2010
2	Vasopressin Receptors (Arginine Vasopressin Receptor)IBA 01/2018 - 01/2006
2	GonadotropinsIBA 12/2017 - 08/2009
2	AutoantibodiesIBA 01/2015 - 06/2014
2	AndrogensIBA 01/2015 - 01/2008
2	Thyrotropin-Releasing Hormone Receptors (Thyrotropin Releasing Hormone Receptor)IBA 09/2014 - 01/2013
2	Member 3 Solute Carrier Family 12IBA 01/2014 - 06/2010
2	CholesterolIBA 04/2012 - 01/2006
2	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 05/2009 - 11/2004
2	thiazide receptorIBA 07/2008 - 01/2006
2	Insulin-Like Growth Factor I (IGF-1)IBA 07/2008 - 02/2002
2	steroidogenic acute regulatory proteinIBA 03/2008 - 01/2008
2	Hydrochlorothiazide (Esidrix)FDA LinkGeneric 12/2003 - 07/2002
1	Prednisolone (Predate)FDA LinkGeneric 01/2023
1	Cortodoxone (11 Deoxycortisol)IBA 11/2022
1	21-deoxycortisolIBA 11/2022
1	Androstenedione (4 Androstene 3,17 dione)IBA 11/2022
1	Creatine Kinase (Creatine Phosphokinase)IBA 10/2022
1	IsoenzymesIBA 10/2022
1	BNT162 VaccineIBA 10/2022
1	C-Reactive ProteinIBA 10/2022
1	Troponin T (Troponin T1)IBA 10/2022
1	VaccinesIBA 10/2022
1	Amino Acids FDA Link 01/2022
1	6-chloro-2-(1-piperazinyl)pyrazine (CPP)IBA 01/2022
1	Blocking AntibodiesIBA 01/2021

Therapy/Procedure

8	Therapeutics 01/2017 - 07/2002
2	Drug Therapy (Chemotherapy) 05/2009 - 10/2008
1	Ligation 02/2024